回复：前列腺癌激素治疗的里程碑。 - Suppr

Suppr

超能文献

Reply: Landmarks in hormonal therapy for prostate cancer.

作者信息

Hammerer Peter, Madersbacher Stephan

出版信息

BJU Int. 2013 Mar;111(3):E13-5. doi: 10.1111/bju.12020_7.

DOI:10.1111/bju.12020_7

PMID:23444931

Abstract

摘要

相似文献

Reply: Landmarks in hormonal therapy for prostate cancer.

BJU Int. 2013 Mar;111(3):E13-5. doi: 10.1111/bju.12020_7.

Landmarks in hormonal therapy for prostate cancer.

BJU Int. 2013 Mar;111(3):E12-3. doi: 10.1111/bju.12020_6.

Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer-Reply.

JAMA. 2016 Oct 4;316(13):1409-1410. doi: 10.1001/jama.2016.9781.

Global update on the use of hormonal therapy for the management of high-risk prostate cancer: introduction.

BJU Int. 2007 Jan;99 Suppl 1:1. doi: 10.1111/j.1464-410X.2007.06590.x.

Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

Br J Cancer. 2013 May 28;108(10):2194. doi: 10.1038/bjc.2013.211. Epub 2013 Apr 30.

Androgen suppression plus radiation for prostate cancer.

JAMA. 2004 Dec 1;292(21):2581-2; author reply 2582. doi: 10.1001/jama.292.21.2581-b.

Primary androgen deprivation therapy in men with prostate cancer.

JAMA. 2009 Jan 7;301(1):35; author reply 35. doi: 10.1001/jama.2008.903.

Role of radiation and androgen deprivation therapy for advanced prostate cancer.

Curr Probl Cancer. 2015 Jan-Feb;39(1):41-7. doi: 10.1016/j.currproblcancer.2014.11.007. Epub 2014 Nov 25.

Hormone therapy for prostate cancer: what have we done with Charles Huggins' legacy?

Eur Urol. 2012 Jan;61(1):26-8. doi: 10.1016/j.eururo.2011.09.005. Epub 2011 Sep 15.

Androgen-independent prostate cancer: a growth area?

BJU Int. 2003 Dec;92(9):1037-8. doi: 10.1111/j.1464-410x.2003.04538.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Reply: Landmarks in hormonal therapy for prostate cancer.

BJU Int. 2013 Mar;111(3):E13-5. doi: 10.1111/bju.12020_7.

Landmarks in hormonal therapy for prostate cancer.

BJU Int. 2013 Mar;111(3):E12-3. doi: 10.1111/bju.12020_6.

Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer-Reply.

JAMA. 2016 Oct 4;316(13):1409-1410. doi: 10.1001/jama.2016.9781.

Global update on the use of hormonal therapy for the management of high-risk prostate cancer: introduction.

BJU Int. 2007 Jan;99 Suppl 1:1. doi: 10.1111/j.1464-410X.2007.06590.x.

Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

Br J Cancer. 2013 May 28;108(10):2194. doi: 10.1038/bjc.2013.211. Epub 2013 Apr 30.

Androgen suppression plus radiation for prostate cancer.

JAMA. 2004 Dec 1;292(21):2581-2; author reply 2582. doi: 10.1001/jama.292.21.2581-b.

Primary androgen deprivation therapy in men with prostate cancer.

JAMA. 2009 Jan 7;301(1):35; author reply 35. doi: 10.1001/jama.2008.903.

Role of radiation and androgen deprivation therapy for advanced prostate cancer.

Curr Probl Cancer. 2015 Jan-Feb;39(1):41-7. doi: 10.1016/j.currproblcancer.2014.11.007. Epub 2014 Nov 25.

Hormone therapy for prostate cancer: what have we done with Charles Huggins' legacy?

Eur Urol. 2012 Jan;61(1):26-8. doi: 10.1016/j.eururo.2011.09.005. Epub 2011 Sep 15.

Androgen-independent prostate cancer: a growth area?

BJU Int. 2003 Dec;92(9):1037-8. doi: 10.1111/j.1464-410x.2003.04538.x.